Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alberto Palacios Cañas has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reproducibilidad clínica de reacciones de hipersensibilidad a fármacos en pruebas de exposición controlada

    by Alberto Palacios Cañas, Jaime Vinicio Meneses Sotomayor, Míriam Clar Castelló, Elisa Gómez Torrijos, Jesús María Borja Segade, Rosa García Rodríguez

    Background Diagnosis of drug hypersensitivity bases on detailed clinical history and skin and challenge tests, which may involve an unaffordable risk. Knowing the reproducibility of reactions could help on the decision of performing them according to safety criteria. Objective The aim was to assess the reproducibility of symptoms in drug challenge tests. Methods The study included patients with positive cutaneous or challenge test throughout 2019. For each patient, clinical suspicion according to Karch-Lasagna algorithm was registered. Primary outcome was the reproducibility of symptoms in the provocation tests using a paired analysis of data with McNemar test. Results Eighty nine patients were included, 16 of them presented more than one positive test. Thirty were skin tests positive and 75 reacted to provocation tests. Eighty nine percent of patients who reacted in challenge test were probably or possibly reactors according to Karch-Lasagna scale. Symptoms of initial reaction did not differ from those triggered in challenge tests. Conclusions Karch-Lasagna scale is useful in predicting the response to drug provocation tests. In most of the positive studies, results were suggested by clinical history and no differences were found between symptoms triggered in challenge test and that referred to in the previous reaction.

  • Open Access

    Combined LTP Sublingual and Oral Immunotherapy in LTP Syndrome: Efficacy and Safety

    by Maria Aranzazu Martin Iglesias, Rosa Garcia Rodriguez, Alberto Palacios Cañas, Jaime Vinicio Meneses Sotomayor, Miriam Clar Castello, Francisco Feo Brito

    Introduction: SLIT for the treatment of plant food allergies has been demonstrated to be safe but less effective than OIT, but the latter is associated with more adverse reactions. The aim of the study was to evaluate the efficacy and safety of a new protocol starting with SLIT-peach followed by OIT with commercial peach juice in patients with LTP syndrome. Methods: This was a prospective, noncontrolled, open study on patients with LTP syndrome who are not sensitized to storage proteins. SLIT peach ALK was followed by OIT with Granini® peach juice after 40 days of the SLIT maintenance phase. At home, the Granini® juice dose was progressively increased during the 42 days until reaching 200 ml. After achieving the maximum dose, an open oral food challenge was carried out with the food that had caused the most severe reaction. If negative, the patient was instructed to progressively introduce the foods that were avoided before starting immunotherapy at home. Patients were reviewed 1 month later. The quality-of-life questionnaire FAQLQ-AF was completed at the beginning of the study and one month after the final challenge. Results: Forty-five patients were included, most of them with LTP anaphylaxis. Peach SLIT was well tolerated in 80.5%, and OIT with Granini® was well tolerated in 85%, with no severe adverse reactions. The final provocation was successful in 39/45 (86.6%). One month after the final provocation, 42/45 (93.3%) patients had no dietary restrictions. FAQLA-AF was significantly reduced. Conclusions: This combination of peach SLIT and OIT with commercial peach juice provides a new, fast, effective, and safe immunotherapy option for selected patients with LTP syndrome who are not allergic to storage proteins, improving their quality of life. This study suggests that cross-desensitization relative to the nsLTPs of several plant foods can be achieved by using Prup3.


  • Maculopapular rash due to delayed‐type hypersensitivity from bismuth salts

    by Alejandro Raúl Gratacós Gómez, Juana Bautista Joyanes Romo, Jaime Vinicio Meneses Sotomayor, Oscar Marcelo González Jimenez, Alberto Palacios Cañas, Elisa Gómez Torrijos


  • Severe maculopapular eruption due to pseudoephedrine in a combination drug, with cross‐reactivity to phenylephrine

    by Alejandro Raúl Gratacós Gómez, Oscar Marcelo González Jimenez, Alberto Palacios Cañas, Lucia Moreno Lozano, Miguel Juan Cencerrado, Elisa Gómez Torrijos


  • Allergic contact dermatitis to red tattoo ink with positive patch tests

    by Elisa Gómez Torrijos, Mónica Garcia Arpa, Alejandro Raúl Gratacós Gómez, Maria Rogel Vence, Ana Rojas Parra, Alberto Palacios Cañas